Ahn-Gook Pharmaceuticals Co., Ltd
Clinical trials sponsored by Ahn-Gook Pharmaceuticals Co., Ltd, explained in plain language.
A South Korean pharmaceutical company producing generic and OTC drugs.
Not investment advice. Company information is shown for context only. Clinical trials frequently fail.
Advertising disclosure. Links marked "(ad)" go to partners we have a commercial relationship with, either a broker where you can trade or a stock-research service, and we may earn a commission if you open an account or subscribe. This never affects what is shown here.
-
New drug candidate AGSAVI aims to lower stubborn high blood pressure
Disease control CompletedThis phase 3 study tests whether the drug AGSAVI can lower blood pressure in people with essential hypertension that is not well controlled by the drug AGLS. About 318 adults with high blood pressure will receive either AGSAVI or AGLS, and their sitting blood pressure will be mea…
Phase 3 • Sponsor: Ahn-Gook Pharmaceuticals Co.,Ltd • Aim: Disease control
Last updated Sep 12, 2026 00:00 UTC
-
New cholesterol drugs show promise in Late-Stage trial
Disease control CompletedThis completed Phase 3 trial tested two new drugs, AG2304T and AG2304R, in 158 adults with primary hypercholesterolemia (high cholesterol). The study compared these drugs to an active control to see how well they lower LDL cholesterol and to check for side effects. Results could …
Phase 3 • Sponsor: Ahn-Gook Pharmaceuticals Co.,Ltd • Aim: Disease control
Last updated Jun 27, 2026 14:00 UTC
-
Can two bronchitis drugs be taken together safely?
Knowledge-focused CompletedThis early-stage trial tests two experimental drugs, AG2203L and AG2203E, in healthy adults to see if they are safe when taken together and whether they affect each other. Participants receive each drug alone and then both together in a random order. The goal is to measure how th…
Phase 1 • Sponsor: Ahn-Gook Pharmaceuticals Co.,Ltd • Aim: Knowledge-focused
Last updated Sep 03, 2026 00:00 UTC